SeaBridge Investment Advisors’s Editas Medicine EDIT Stock Holding History

SeaBridge Investment Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$6K	–	166
2020 Q3	$6K	Hold	200	–	–	﹤0.01%	240
2020 Q2	$6K	Hold	200	–	–	﹤0.01%	239
2020 Q1	$4K	Hold	200	–	–	﹤0.01%	245
2019 Q4	$6K	Hold	200	–	–	﹤0.01%	239
2019 Q3	$5K	Hold	200	–	–	﹤0.01%	253
2019 Q2	$5K	Hold	200	–	–	﹤0.01%	246
2019 Q1	$5K	Hold	200	–	–	﹤0.01%	239
2018 Q4	$5K	Hold	200	–	–	﹤0.01%	232
2018 Q3	$6K	Hold	200	–	–	﹤0.01%	228
2018 Q2	$7K	Hold	200	–	–	﹤0.01%	235
2018 Q1	$7K	Buy	+200	New	+$7.13K	﹤0.01%	231

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

SeaBridge Investment Advisors's EDIT Position: Q4 2020 in Review

SeaBridge Investment Advisors sold out of Editas Medicine (EDIT) in Q4 2020, closing a stake of 200 shares — an estimated $6K sold.

SeaBridge Investment Advisors first reported a position in EDIT in Q1 2018 and held it in 11 quarters. The position peaked at $7K in Q2 2018. 311 funds tracked by Wall St. Rank hold EDIT as of Q4 2020.

SeaBridge Investment Advisors reported no remaining Editas Medicine position as of Q4 2020 after selling out during the quarter.
SeaBridge Investment Advisors sold 200 Editas Medicine shares in Q4 2020, an estimated $6K.
SeaBridge Investment Advisors first reported a position in Editas Medicine in Q1 2018 and held it in 11 quarters.
SeaBridge Investment Advisors's Editas Medicine position peaked at $7K in Q2 2018.
311 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2020.

Based on SeaBridge Investment Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.